|
1
|
Sohrabi C, Alsafi Z, O'Neill N, Khan M,
Kerwan A, Al-Jabir A, Iosifidis C and Agha R: World Health
Organization declares global emergency: A review of the 2019 novel
coronavirus (COVID-19). Int J Surg. 76:71–76. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Leaune E, Samuel M, Oh H, Poulet E and
Brunelin J: Suicidal behaviors and ideation during emerging viral
disease outbreaks before the COVID-19 pandemic: A systematic rapid
review. Prev Med. 141(106264)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kahil K, Cheaito MA, El Hayek R, Nofal M,
El Halabi S, Kudva KG, Pereira-Sanchez V and El Hayek S: Suicide
during COVID-19 and other major international respiratory
outbreaks: A systematic review. Asian J Psychiatr.
56(102509)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zoumpourlis V, Goulielmaki M, Rizos E,
Baliou S and Spandidos DA: [Comment] The COVID-19 pandemic as a
scientific and social challenge in the 21st century. Mol Med Rep.
22:3035–3048. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Efstathiou V, Stefanou MI, Siafakas N,
Makris M, Tsivgoulis G, Zoumpourlis V, Spandidos DA, Smyrnis N and
Rizos E: Suicidality and COVID-19: Suicidal ideation, suicidal
behaviors and completed suicides amidst the COVID-19 pandemic
(Review). Exp Ther Med. 23(107)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tsamakis K, Tsiptsios D, Ouranidis A,
Mueller C, Schizas D, Terniotis C, Nikolakakis N, Tyros G,
Kympouropoulos S, Lazaris A, et al: COVID-19 and its consequences
on mental health (Review). Exp Ther Med. 21(244)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tsamakis K, Triantafyllis AS, Tsiptsios D,
Spartalis E, Mueller C, Tsamakis C, Chaidou S, Spandidos DA, Fotis
L, Economou M and Rizos E: COVID-19 related stress exacerbates
common physical and mental pathologies and affects treatment
(Review). Exp Ther Med. 20:159–162. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Han Y, Yuan K, Wang Z, Liu WJ, Lu ZA, Liu
L, Shi L, Yan W, Yuan JL, Li JL, et al: Neuropsychiatric
manifestations of COVID-19, potential neurotropic mechanisms, and
therapeutic interventions. Transl Psychiatry.
11(499)2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lechien JR, Chiesa-Estomba CM, Place S,
Van Laethem Y, Cabaraux P, Mat Q, Huet K, Plzak J, Horoi M, Hans S,
et al: Clinical and epidemiological characteristics of 1420
European patients with mild-to-moderate coronavirus disease 2019. J
Intern Med. 288:335–344. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ellul MA, Benjamin L, Singh B, Lant S,
Michael BD, Easton A, Kneen R, Defres S, Sejvar J and Solomon T:
Neurological associations of COVID-19. Lancet Neurol. 19:767–783.
2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Varatharaj A, Thomas N, Ellul MA, Davies
NWS, Pollak TA, Tenorio EL, Sultan M, Easton A, Breen G, Zandi M,
et al: Neurological and neuropsychiatric complications of COVID-19
in 153 patients: A UK-wide surveillance study. Lancet Psychiatry.
7:875–882. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Helms J, Kremer S, Merdji H, Clere-Jehl R,
Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S and
Ohana M: Neurologic features in severe SARS-CoV-2 infection. N Engl
J Med. 382:2268–2270. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Iltaf S Sr, Fatima M, Salman S Sr, Salam
JU and Abbas S: Frequency of neurological presentations of
coronavirus disease in patients presenting to a tertiary care
hospital during the 2019 coronavirus disease pandemic. Cureus.
12(e9846)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q,
Chang J, Hong C, Zhou Y, Wang D, et al: Neurologic manifestations
of hospitalized patients with coronavirus disease 2019 in Wuhan,
China. JAMA Neurol. 77:683–690. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Fan S, Xiao M, Han F, Xia P, Bai X, Chen
H, Zhang H, Ding X, Zhao H, Zhao J, et al: Neurological
manifestations in critically ill patients with COVID-19: A
retrospective study. Front Neurol. 11(806)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Xiong W, Mu J, Guo J, Lu L, Liu D, Luo J,
Li N, Liu J, Yang D and Gao H: New onset neurologic events in
people with COVID-19 in 3 regions in China. Neurology.
95:e1479–e1487. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Frontera JA, Sabadia S, Lalchan R, Fang T,
Flusty B, Millar-Vernetti P, Snyder T, Berger S, Yang D, Granger A,
et al: A prospective study of neurologic disorders in hospitalized
patients with COVID-19 in New York City. Neurology. 96:e575–e586.
2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bo HX, Li W, Yang Y, Wang Y, Zhang Q,
Cheung T, Wu X and Xiang YT: Posttraumatic stress symptoms and
attitude toward crisis mental health services among clinically
stable patients with COVID-19 in China. Psychol Med. 51:1052–1053.
2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hu Y, Chen Y, Zheng Y, You C, Tan J, Hu L,
Zhang Z and Ding L: Factors related to mental health of inpatients
with COVID-19 in Wuhan, China. Brain Behav Immun. 89:587–593.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Schou TM, Joca S, Wegener G and
Bay-Richter C: Psychiatric and neuropsychiatric sequelae of
COVID-19-A systematic review. Brain Behav Immun. 97:328–348.
2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Michelen M, Manoharan L, Elkheir N, Cheng
V, Dagens A, Hastie C, Hara M, Suett J, Dahmash D, Bugaeva P, et
al: Characterising long COVID: A living systematic review. BMJ
Global Health. 6(e005427)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Centers for Disease Control and Prevention
(CDC): Post-COVID Conditions: Information for Healthcare Providers.
CDC, Atlanta, GA, 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.
Updated July 9, 2021.
|
|
23
|
Deer RR, Rock MA, Vasilevsky N, Carmody L,
Rando H, Anzalone AJ, Basson MD, Bennett TD, Bergquist T, Boudreau
EA, et al: Characterizing long COVID: Deep phenotype of a complex
condition. EBioMedicine. 74(103722)2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Brodin P: Immune determinants of COVID-19
disease presentation and severity. Nat Med. 27:28–33.
2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Stefanou MI, Palaiodimou L, Bakola E,
Smyrnis N, Papadopoulou M, Paraskevas GP, Rizos E, Boutati E,
Grigoriadis N, Krogias C, et al: Neurological manifestations of
long-COVID syndrome: A narrative review. Ther Adv Chronic Dis.
13(20406223221076890)2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Soriano JB, Murthy S, Marshall JC, Relan P
and Diaz JV: WHO Clinical Case Definition Working Group on
Post-COVID-19 Condition. A clinical case definition of
post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis.
22:e102–e107. 2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Rajan S, Khunti K, Alwan N, Steves C,
Greenhalgh T, MacDermott N, Sagan A and McKee M: In the wake of the
pandemic. Preparing for Long COVID Policy Brief.
(39)2021.PubMed/NCBI
|
|
28
|
Fernández-de-Las-Peñas C, Palacios-Ceña D,
Gómez-Mayordomo V, Cuadrado ML and Florencio LL: Defining
Post-COVID symptoms (Post-Acute COVID, Long COVID, Persistent
Post-COVID): An integrative classification. Int J Environ Res
Public Health. 18(2621)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Davis HE, Assaf GS, McCorkell L, Wei H,
Low RJ, Re'em Y, Redfield S, Austin JP and Akrami A: Characterizing
long COVID in an international cohort: 7 months of symptoms and
their impact. EClinicalMedicine. 38(101019)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Al-Aly Z, Xie Y and Bowe B:
High-dimensional characterization of post-acute sequelae of
COVID-19. Nature. 594:259–264. 2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lopez-Leon S, Wegman-Ostrosky T, Perelman
C, Sepulveda R, Rebolledo PA, Cuapio A and Villapol S: More than 50
long-term effects of COVID-19: A systematic review and
meta-analysis. Sci Rep. 11(16144)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Lamontagne SJ, Winters MF, Pizzagalli DA
and Olmstead MC: Post-acute sequelae of COVID-19: Evidence of mood
& cognitive impairment. Brain Behav Immun Health.
17(100347)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Jesuthasan A, Massey F, Manji H, Zandi MS
and Wiethoff S: Emerging potential mechanisms and predispositions
to the neurological manifestations of COVID-19. J Neurol Sci.
428(117608)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Dąbrowska E, Galińska-Skok B and
Waszkiewicz N: Depressive and neurocognitive disorders in the
context of the inflammatory background of COVID-19. Life (Basel).
11(1056)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Flores G: SARS-COV-2 (COVID-19) has
neurotropic and neuroinvasive properties. Int J Clin Pract.
75(e13708)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang
Y, Hu P, Guo L, Liu M, Xu J, et al: 1-year outcomes in hospital
survivors with COVID-19: A longitudinal cohort study. Lancet.
398:747–758. 2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lagadinou M, Kostopoulou E, Karatza A,
Marangos M and Gkentzi D: The prolonged effects of COVID-19. A New
‘Threat’? Eur Rev Med Pharmacol Sci. 25:4611–4615. 2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Shanbehzadeh S, Tavahomi M, Zanjari N,
Ebrahimi-Takamjani I and Amiri-Arimi S: Physical and mental health
complications post-COVID-19: Scoping review. J Psychosom Res.
147(110525)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Mazza MG, De Lorenzo R, Conte C, Poletti
S, Vai B, Bollettini I, Melloni EMT, Furlan R, Ciceri F,
Rovere-Querini P, et al: Anxiety and depression in COVID-19
survivors: Role of inflammatory and clinical predictors. Brain
Behav Immun. 89:594–600. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Mazza MG, Palladini M, De Lorenzo R,
Magnaghi C, Poletti S, Furlan R, Ciceri F, Rovere-Querini P and
Benedetti F: Persistent psychopathology and neurocognitive
impairment in COVID-19 survivors: Effect of inflammatory biomarkers
at three-month follow-up. Brain Behav Immun. 94:138–147.
2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Huang C, Huang L, Wang Y, Li X, Ren L, Gu
X, Kang L, Guo L, Liu M, Zhou X, et al: 6-month consequences of
COVID-19 in patients discharged from hospital: A cohort study.
Lancet. 397:220–232. 2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Taquet M, Geddes JR, Husain M, Luciano S
and Harrison PJ: 6-month neurological and psychiatric outcomes in
236 379 survivors of COVID-19: A retrospective cohort study using
electronic health records. Lancet Psychiatry. 8:416–427.
2021.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Bourmistrova NW, Solomon T, Braude P,
Strawbridge R and Carter B: Long-term effects of COVID-19 on mental
health: A systematic review. J Affect Disord. 299:118–125.
2022.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Young AS, Klap R, Shoai R and Wells KB:
Persistent depression and anxiety in the United States: Prevalence
and quality of care. Psychiatr Serv. 59:1391–1398. 2008.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Renaud-Charest O, Lui LMW, Eskander S,
Ceban F, Ho R, Di Vincenzo JD, Rosenblat JD, Lee Y,
Subramaniapillai M and McIntyre RS: Onset and frequency of
depression in post-COVID-19 syndrome: A systematic review. J
Psychiatr Res. 144:129–137. 2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
De Lorenzo R, Cinel E, Cilla M, Compagnone
N, Ferrante M, Falbo E, Patrizi A, Castellani J, Magnaghi C,
Calvisi SL, et al: Physical and psychological sequelae at three
months after acute illness in COVID-19 survivors. Panminerva Med:
Jun 1, 2021 (Epub ahead of print). doi:
10.23736/S0031-0808.21.04399-8.
|
|
47
|
Sykes DL, Holdsworth L, Jawad N,
Gunasekera P, Morice AH and Crooks MG: Post-COVID-19 Symptom
Burden: What is Long-COVID and how should we manage it? Lung.
199:113–119. 2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Morin L, Savale L, Pham T, Colle R,
Figueiredo S, Harrois A, Gasnier M, Lecoq AL, Meyrignac O and Noel
N: Four-month clinical status of a cohort of patients after
hospitalization for COVID-19. JAMA. 325:1525–1534. 2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Boari GEM, Bonetti S, Braglia-Orlandini F,
Chiarini G, Faustini C, Bianco G, Santagiuliana M, Guarinoni V,
Saottini M, Viola S, et al: Short-term consequences of
SARS-CoV-2-related pneumonia: A follow up study. High Blood Press
Cardiovasc Prev. 28:373–381. 2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Gautam N, Madathil S, Tahani N, Bolton S,
Parekh D, Stockley J, Goyal S, Qureshi H, Yasmin S, Cooper BG, et
al: Medium-term outcome of severe to critically ill patients with
Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Clin
Infect Dis. 74:301–308. 2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Benedetti F, Palladini M, Paolini M,
Melloni E, Vai B, De Lorenzo R, Furlan R, Rovere-Querini P, Falini
A and Mazza MG: Brain correlates of depression, post-traumatic
distress, and inflammatory biomarkers in COVID-19 survivors: A
multimodal magnetic resonance imaging study. Brain Behav Immun
Health. 18(100387)2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Fernández-de-Las-Peñas C, Gómez-Mayordomo
V, de-la-Llave-Rincón AI, Palacios-Ceña M, Rodríguez-Jiménez J,
Florencio LL, Velasco-Arribas M, Fuensalida-Novo S, Cigarán-Méndez
M, Ambite-Quesada S, et al: Anxiety, depression and poor sleep
quality as long-term post-COVID sequelae in previously hospitalized
patients: A multicenter study. J Infect. 83:496–522.
2021.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Pilotto A, Cristillo V, Cotti Piccinelli
S, Zoppi N, Bonzi G, Sattin D, Schiavolin S, Raggi A, Canale A,
Gipponi S, et al: Long-term neurological manifestations of
COVID-19: prevalence and predictive factors. Neurol Sci.
42:4903–4907. 2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Méndez R, Balanzá-Martínez V, Luperdi SC,
Estrada I, Latorre A, González-Jiménez P, Bouzas L, Yépez K,
Ferrando A, Reyes S, et al: Long-term neuropsychiatric outcomes in
COVID-19 survivors: A 1-year longitudinal study. J Intern Med.
291:247–251. 2022.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Zhang X, Wang F, Shen Y, Zhang X, Cen Y,
Wang B, Zhao S, Zhou Y, Hu B, Wang M, et al: Symptoms and Health
Outcomes Among Survivors of COVID-19 Infection 1 Year After
Discharge From Hospitals in Wuhan, China. JAMA Netw Open.
4(e2127403)2021.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Matalon N, Dorman-Ilan S, Hasson-Ohayon I,
Hertz-Palmor N, Shani S, Basel D, Gross R, Chen W, Abramovich A and
Afek A: Trajectories of post-traumatic stress symptoms, anxiety,
and depression in hospitalized COVID-19 patients: A one-month
follow-up. J Psychosom Res. 143(110399)2021.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Alemanno F, Houdayer E, Parma A, Spina A,
Del Forno A, Scatolini A, Angelone S, Brugliera L, Tettamanti A and
Beretta L: COVID-19 cognitive deficits after respiratory assistance
in the subacute phase: A COVID-rehabilitation unit experience. PLoS
One. 16(e0246590)2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Halpin SJ, McIvor C, Whyatt G, Adams A,
Harvey O, McLean L, Walshaw C, Kemp S, Corrado J and Singh R:
Postdischarge symptoms and rehabilitation needs in survivors of
COVID-19 infection: A cross-sectional evaluation. J Med Virol.
93:1013–1022. 2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
de Graaf MA, Antoni ML, Ter Kuile MM,
Arbous MS, Duinisveld AJF, Feltkamp MCW, Groeneveld GH, Hinnen SCH,
Janssen VR, Lijfering WM, et al: Short-term outpatient follow-up of
COVID-19 patients: A multidisciplinary approach. EClinicalMedicine.
32(100731)2021.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Albu S, Zozaya NR, Murillo N,
García-Molina A, Chacón CAF and Kumru H: What's going on following
acute COVID-19? Clinical characteristics of patients in an
out-patient rehabilitation program. NeuroRehabilitation.
48:469–480. 2021.PubMed/NCBI View Article : Google Scholar
|
|
61
|
van den Borst B, Peters JB, Brink M,
Schoon Y, Bleeker-Rovers CP, Schers H, van Hees HWH, van Helvoort
H, van den Boogaard M, van der Hoeven H, et al: Comprehensive
health assessment 3 months after recovery from acute coronavirus
disease 2019 (COVID-19). Clin Infect Dis. 73:e1089–e1098.
2021.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Rass V, Beer R, Schiefecker AJ, Kofler M,
Lindner A, Mahlknecht P, Heim B, Limmert V, Sahanic S, Pizzini A,
et al: Neurological outcome and quality of life 3 months after
COVID-19: A prospective observational cohort study. Eur J Neurol.
28:3348–3359. 2021.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Yuan B, Li W, Liu H, Cai X, Song S, Zhao
J, Hu X, Li Z, Chen Y, Zhang K, et al: Correlation between immune
response and self-reported depression during convalescence from
COVID-19. Brain Behav Immun. 88:39–43. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Wong AW, Shah AS, Johnston JC, Carlsten C
and Ryerson CJ: Patient-reported outcome measures after COVID-19: A
prospective cohort study. Eur Respir J. 56(200327)2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Tomasoni D, Bai F, Castoldi R, Barbanotti
D, Falcinella C, Mulè G, Mondatore D, Tavelli A, Vegni E, Marchetti
G and d'Arminio Monforte A: Anxiety and depression symptoms after
virological clearance of COVID-19: A cross-sectional study in
Milan, Italy. J Med Virol. 93:1175–1179. 2021.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Wu C, Hu X, Song J, Yang D, Xu J, Cheng K,
Chen D, Zhong M, Jiang J, Xiong W, et al: Mental health status and
related influencing factors of COVID-19 survivors in Wuhan, China.
Clin Transl Med. 10(e52)2020.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Romero-Duarte Á, Rivera-Izquierdo M,
Guerrero-Fernández de Alba I, Pérez-Contreras M, Fernández-Martínez
NF, Ruiz-Montero R, Serrano-Ortiz Á, González-Serna RO,
Salcedo-Leal I, Jiménez-Mejías E and Cárdenas-Cruz A: Sequelae,
persistent symptomatology and outcomes after COVID-19
hospitalization: The ANCOHVID multicentre 6-month follow-up study.
BMC Med. 19(129)2021.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Kaseda ET and Levine AJ: Post-traumatic
stress disorder: A differential diagnostic consideration for
COVID-19 survivors. Clin Neuropsychol. 34:1498–1514.
2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Giannopoulou I, Galinaki S, Kollintza E,
Adamaki M, Kympouropoulos S, Alevyzakis E, Tsamakis K, Tsangaris I,
Spandidos DA, Siafakas N, et al: COVID-19 and post-traumatic stress
disorder: The perfect ‘storm’ for mental health (Review). Exp Ther
Med. 22(1162)2021.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Naidu SB, Shah AJ, Saigal A, Smith C,
Brill SE, Goldring J, Hurst JR, Jarvis H, Lipman M and Mandal S:
The high mental health burden of ʻLong COVIDʼ and its association
with on-going physical and respiratory symptoms in all adults
discharged from hospital. Eur Respir J. 57(2004364)2021.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Venturelli S, Benatti SV, Casati M, Binda
F, Zuglian G, Imeri G, Conti C, Biffi AM, Spada MS, Bondi E, et al:
Surviving COVID-19 in Bergamo province: A post-acute outpatient
re-evaluation. Epidemiol Infect. 149(e32)2021.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Evans RA, McAuley H, Harrison EM, Shikotra
A, Singapuri A, Sereno M, Elneima O, Docherty AB, Lone NI, Leavy
OC, et al: Physical, cognitive, and mental health impacts of
COVID-19 after hospitalisation (PHOSP-COVID): A UK multicentre,
prospective cohort study. Lancet Respir Med. 9:1275–1287.
2021.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Bellan M, Soddu D, Balbo PE, Baricich A,
Zeppegno P, Avanzi GC, Baldon G, Bartolomei G, Battaglia M,
Battistini S, et al: Respiratory and psychophysical sequelae among
patients with COVID-19 four months after hospital discharge. JAMA
Network Open. 4(e2036142)2021.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Horn M, Wathelet M, Fovet T, Amad A,
Vuotto F, Faure K, Astier T, Noël H, Henry M and Duhem S: Is
COVID-19 associated with posttraumatic stress disorder? J Clin
Psychiatry. 82(9886)2020.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Tarsitani L, Vassalini P, Koukopoulos A,
Borrazzo C, Alessi F, Di Nicolantonio C, Serra R, Alessandri F,
Ceccarelli G, Mastroianni CM, et al: Post-traumatic stress disorder
among COVID-19 survivors at 3-month follow-up after hospital
discharge. J Gen Intern Med. 36:1702–1707. 2021.PubMed/NCBI View Article : Google Scholar
|
|
76
|
De Lorenzo R, Conte C, Lanzani C,
Benedetti F, Roveri L, Mazza MG, Brioni E, Giacalone G, Canti V,
Sofia V, et al: Residual clinical damage after COVID-19: A
retrospective and prospective observational cohort study. PLoS One.
15(e0239570)2020.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Poyraz BÇ, Poyraz CA, Olgun Y, Gürel Ö,
Alkan S, Özdemir YE, Balkan İİ and Karaali R: Psychiatric morbidity
and protracted symptoms after COVID-19. Psychiatry Res.
295(113604)2021.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Nalbandian A, Sehgal K, Gupta A, Madhavan
MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat
TS, et al: Post-acute COVID-19 syndrome. Nat Med. 27:601–615.
2021.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Sun LL, Wang J, Wang YS, Hu PF, Zhao ZQ,
Chen W, Ning BF, Yin C, Hao YS, Wang Q, et al: Symptomatic features
and prognosis of 932 hospitalized patients with coronavirus disease
2019 in Wuhan. J Dig Dis. 22:271–281. 2021.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Augustin M, Schommers P, Stecher M, Dewald
F, Gieselmann L, Gruell H, Horn C, Vanshylla K, Cristanziano VD,
Osebold L, et al: Post-COVID syndrome in non-hospitalised patients
with COVID-19: A longitudinal prospective cohort study. Lancet Reg
Health Eur. 6(100122)2021.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Shang YF, Liu T, Yu JN, Xu XR, Zahid KR,
Wei YC, Wang XH and Zhou FL: Half-year follow-up of patients
recovering from severe COVID-19: Analysis of symptoms and their
risk factors. J Intern Med. 290:444–450. 2021.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Grandner MA: Sleep, health, and society.
Sleep Med Clin. 12:1–22. 2017.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Freeman D, Sheaves B, Waite F, Harvey AG
and Harrison PJ: Sleep disturbance and psychiatric disorders.
Lancet Psychiatry. 7:628–637. 2020.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Ceban F, Ling S, Lui LMW, Lee Y, Gill H,
Teopiz KM, Rodrigues NB, Subramaniapillai M, Di Vincenzo JD, Cao B,
et al: Fatigue and cognitive impairment in Post-COVID-19 Syndrome:
A systematic review and meta-analysis. Brain Behav Immun.
101:93–135. 2021.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Townsend L, Dyer AH, Naughton A, Kiersey
R, Holden D, Gardiner M, Dowds J, O'Brien K, Bannan C, Nadarajan P,
et al: Longitudinal analysis of COVID-19 patients shows
age-associated T cell changes independent of ongoing Ill-health.
Front Immunol. 12(676932)2021.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Fernández-de-Las-Peñas C, Palacios-Ceña D,
Gómez-Mayordomo V, Rodríuez-Jiménez J, Palacios-Ceña M,
Velasco-Arribas M, Guijarro C, de-la-Llave-Rincón AI,
Fuensalida-Novo S, Elvira-Martínez CM, et al: Long-term post-COVID
symptoms and associated risk factors in previously hospitalized
patients: A multicenter study. J Infect. 83:237–279.
2021.PubMed/NCBI View Article : Google Scholar
|
|
87
|
González-Hermosillo JA, Martínez-López JP,
Carrillo-Lampón SA, Ruiz-Ojeda D, Herrera-Ramírez S, Amezcua-Guerra
LM and Martínez-Alvarado MDR: Post-acute COVID-19 symptoms, a
potential Link with Myalgic Encephalomyelitis/Chronic fatigue
syndrome: A 6-month survey in a Mexican cohort. Brain Sci.
11(760)2021.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Menges D, Ballouz T, Anagnostopoulos A,
Aschmann HE, Domenghino A, Fehr JS and Puhan MA: Burden of
post-COVID-19 syndrome and implications for healthcare service
planning: A population-based cohort study. PLoS One.
16(e0254523)2021.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Stavem K, Ghanima W, Olsen MK, Gilboe HM
and Einvik G: Prevalence and determinants of fatigue after COVID-19
in Non-hospitalized subjects: A Population-based study. Int J
Environ Res Public Health. 18(2030)2021.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Peghin M, Palese A, Venturini M, De
Martino M, Gerussi V, Graziano E, Bontempo G, Marrella F, Tommasini
A, Fabris M, et al: Post-COVID-19 symptoms 6 months after acute
infection among hospitalized and non-hospitalized patients. Clin
Microbiol Infect. 27:1507–1513. 2021.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Liang L, Yang B, Jiang N, Fu W, He X, Zhou
Y, Ma WL and Wang X: Three-month Follow-up study of survivors of
coronavirus disease 2019 after discharge. J Korean Med Sci.
35:e418. 2020.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Daroische R, Hemminghyth MS, Eilertsen TH,
Breitve MH and Chwiszczuk LJ: Cognitive impairment after COVID-19-A
review on objective test data. Front Neurol.
12(699582)2021.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Rogers JP, Chesney E, Oliver D, Pollak TA,
McGuire P, Fusar-Poli P, Zandi MS, Lewis G and David AS:
Psychiatric and neuropsychiatric presentations associated with
severe coronavirus infections: A systematic review and
meta-analysis with comparison to the COVID-19 pandemic. Lancet
Psychiatry. 7:611–627. 2020.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Méndez R, Balanzá-Martínez V, Luperdi SC,
Estrada I, Latorre A, González-Jiménez P, Feced L, Bouzas L, Yépez
K, Ferrando A, et al: Short-term neuropsychiatric outcomes and
quality of life in COVID-19 survivors. J Intern Med. 290:621–631.
2021.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Desforges M, Le Coupanec A, Dubeau P,
Bourgouin A, Lajoie L, Dubé M and Talbot PJ: Human coronaviruses
and other respiratory viruses: Underestimated opportunistic
pathogens of the central nervous system? Viruses.
12(14)2019.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Li CW, Syue LS, Tsai YS, Li MC, Lo CL,
Tsai CS, Chen PL, Ko WC and Lee NY: Anosmia and olfactory tract
neuropathy in a case of COVID-19. J Microbiol Immunol Infect.
54:93–96. 2021.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Lin E, Lantos JE, Strauss SB, Phillips CD,
Campion TR Jr, Navi BB, Parikh NS, Merkler AE, Mir S, Zhang C, et
al: Brain imaging of patients with COVID-19: Findings at an
academic institution during the height of the outbreak in New York
City. AJNR Am J Neuroradiol. 41:2001–2008. 2020.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Lu S, Wei N, Jiang J, Wu L, Sheng J, Zhou
J, Fang Q, Chen Y, Zheng S, Chen F, et al: First report of
manic-like symptoms in a COVID-19 patient with no previous history
of a psychiatric disorder. J Affect Disord. 277:337–340.
2020.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Najjar S, Najjar A, Chong DJ, Pramanik BK,
Kirsch C, Kuzniecky RI, Pacia SV and Azhar S: Central nervous
system complications associated with SARS-CoV-2 infection:
Integrative concepts of pathophysiology and case reports. J
Neuroinflammation. 17(231)2020.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Muus C, Luecken MD, Eraslan G, Waghray A,
Heimberg G, Sikkema L, Kobayashi Y, Vaishnav ED, Subramanian A,
Smilie C, et al: Integrated analyses of single-cell atlases reveal
age, gender, and smoking status associations with cell
type-specific expression of mediators of SARS-CoV-2 viral entry and
highlights inflammatory programs in putative target cells. bioRxiv:
https://doi.org/10.1101/2020.04.19.049254.
|
|
101
|
Rhea EM, Logsdon AF, Hansen KM, Williams
LM, Reed MJ, Baumann KK, Holden SJ, Raber J, Banks WA and Erickson
MA: The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in
mice. Nat Neurosci. 24:368–378. 2021.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Gheblawi M, Wang K, Viveiros A, Nguyen Q,
Zhong JC, Turner AJ, Raizada MK, Grant MB and Oudit GY:
Angiotensin-converting Enzyme 2: SARS-CoV-2 receptor and regulator
of the renin-angiotensin system: Celebrating the 20th anniversary
of the discovery of ACE2. Circ Res. 126:1456–1474. 2020.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Inoue Y, Tanaka N, Tanaka Y, Inoue S,
Morita K, Zhuang M, Hattori T and Sugamura K: Clathrin-dependent
entry of severe acute respiratory syndrome coronavirus into target
cells expressing ACE2 with the cytoplasmic tail deleted. J Virol.
81:8722–8729. 2007.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Wrapp D, Wang N, Corbett KS, Goldsmith JA,
Hsieh CL, Abiona O, Graham BS and McLellan JS: Cryo-EM structure of
the 2019-nCoV spike in the prefusion conformation. Science.
367:1260–1263. 2020.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Wang K, Chen W, Zhang Z, Deng Y, Lian JQ,
Du P, Wei D, Zhang Y, Sun XX, Gong L, et al: CD147-spike protein is
a novel route for SARS-CoV-2 infection to host cells. Signal
Transduct Target Ther. 5(283)2020.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Dantzer R: Neuroimmune Interactions: From
the Brain to the immune system and vice versa. Physiol Rev.
98:477–504. 2018.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Ye Q, Wang B and Mao J: The pathogenesis
and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect.
80:607–613. 2020.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Park MD: Macrophages: A Trojan horse in
COVID-19? Nat Rev Immunol. 20(351)2020.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Cameron MJ, Bermejo-Martin JF, Danesh A,
Muller MP and Kelvin DJ: Human immunopathogenesis of severe acute
respiratory syndrome (SARS). Virus Res. 133:13–19. 2008.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Miller AH and Raison CL: The role of
inflammation in depression: From evolutionary imperative to modern
treatment target. Nat Rev Immunol. 16:22–34. 2016.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Ozbay F, Johnson DC, Dimoulas E, Morgan
CA, Charney D and Southwick S: Social support and resilience to
stress: From neurobiology to clinical practice. Psychiatry
(Edgmont). 4:35–40. 2007.PubMed/NCBI
|
|
112
|
Smith SM and Vale WW: The role of the
hypothalamic-pituitary-adrenal axis in neuroendocrine responses to
stress. Dialogues Clin Neurosci. 8:383–395. 2006.PubMed/NCBI View Article : Google Scholar
|
|
113
|
de Pablos RM, Herrera AJ, Espinosa-Oliva
AM, Sarmiento M, Muñoz MF, Machado A and Venero JL: Chronic stress
enhances microglia activation and exacerbates death of nigral
dopaminergic neurons under conditions of inflammation. J
Neuroinflammation. 11(34)2014.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Schoenfeld TJ and Gould E: Stress, stress
hormones, and adult neurogenesis. Exp Neurol. 233:12–21.
2012.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Futtrup J, Margolinsky R, Benros ME, Moos
T, Routhe LJ, Rungby J and Krogh J: Blood-brain barrier pathology
in patients with severe mental disorders: A systematic review and
meta-analysis of biomarkers in case-control studies. Brain Behav
Immun Health. 6(100102)2020.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Tremblay ME, Madore C, Bordeleau M, Tian L
and Verkhratsky A: Neuropathobiology of COVID-19: The role for
glia. Front Cell Neurosci. 14(592214)2020.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Zhou H, Lu S, Chen J, Wei N, Wang D, Lyu
H, Shi C and Hu S: The landscape of cognitive function in recovered
COVID-19 patients. J Psychiatr Res. 129:98–102. 2020.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Mazza MG, Lucchi S, Tringali AGM, Rossetti
A, Botti ER and Clerici M: Neutrophil/lymphocyte ratio and
platelet/lymphocyte ratio in mood disorders: A meta-analysis. Prog
Neuropsychopharmacol Biol Psychiatry. 84:229–236. 2018.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Escartin C, Galea E, Lakatos A,
O'Callaghan JP, Petzold GC, Serrano-Pozo A, Steinhäuser C, Volterra
A, Carmignoto G, Agarwal A, et al: Reactive astrocyte nomenclature,
definitions, and future directions. Nat Neurosci. 24:312–325.
2021.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Lee MH, Perl DP, Nair G, Li W, Maric D,
Murray H, Dodd SJ, Koretsky AP, Watts JA, Cheung V, et al:
Microvascular Injury in the Brains of patients with Covid-19. N
Engl J Med. 384:481–483. 2021.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Dietz AG, Goldman SA and Nedergaard M:
Glial cells in schizophrenia: A unified hypothesis. Lancet
Psychiatry. 7:272–281. 2020.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Verkhratsky A, Rodríguez JJ and Steardo L:
Astrogliopathology: A central element of neuropsychiatric diseases?
Neuroscientist. 20:576–588. 2014.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Barbic F, Heusser K, Minonzio M, Shiffer
D, Cairo B, Tank J, Jordan J, Diedrich A, Gauger P, Zamuner RA, et
al: Effects of prolonged head-down bed rest on cardiac and vascular
baroreceptor modulation and orthostatic tolerance in healthy
individuals. Front Physiol. 10(1061)2019.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Beck L, Baisch F, Gaffney FA, Buckey JC,
Arbeille P, Patat F, Ten Harkel AD, Hillebrecht A, Schulz H,
Karemaker JM, et al: Cardiovascular response to lower body negative
pressure before, during, and after ten days head-down tilt bedrest.
Acta Physiol Scand Suppl. 604:43–52. 1992.PubMed/NCBI
|
|
125
|
Goldstein DS, Vernikos J, Holmes C and
Convertino VA: Catecholaminergic effects of prolonged head-down bed
rest. J Appl Physiol (1985). 78:1023–1029. 1995.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Kamiya A, Michikami D, Fu Q, Iwase S,
Hayano J, Kawada T, Mano T and Sunagawa K: Pathophysiology of
orthostatic hypotension after bed rest: Paradoxical sympathetic
withdrawal. Am J Physiol Heart Circ Physiol. 285:H1158–H1167.
2003.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Guilmot A, Maldonado Slootjes S, Sellimi
A, Bronchain M, Hanseeuw B, Belkhir L, Yombi JC, De Greef J, Pothen
L, Yildiz H, et al: Immune-mediated neurological syndromes in
SARS-CoV-2-infected patients. J Neurol. 268:751–757.
2021.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Follmer C: Viral infection-induced gut
dysbiosis, neuroinflammation, and α-synuclein aggregation: Updates
and perspectives on COVID-19 and neurodegenerative disorders. ACS
Chem Neurosci. 11:4012–4016. 2020.PubMed/NCBI View Article : Google Scholar
|
|
129
|
McAlpine LS, Zubair AS, Maran I, Chojecka
P, Lleva P, Jasne AS, Navaratnam D, Matouk C, Schindler J, Sheth
KN, et al: Ischemic stroke, inflammation, and endotheliopathy in
COVID-19 patients. Stroke. 52:e233–e238. 2021.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Wang Z, Yang Y, Liang X, Gao B, Liu M, Li
W, Chen Z and Wang Z: COVID-19 associated ischemic stroke and
hemorrhagic stroke: Incidence, potential pathological mechanism,
and management. Front Neurol. 11(571996)2020.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Lu Y, Li X, Geng D, Mei N, Wu PY, Huang
CC, Jia T, Zhao Y, Wang D, Xiao A and Yin B: Cerebral
Micro-structural changes in COVID-19 patients-an MRI-based 3-month
Follow-up study. EClinicalMedicine. 25(100484)2020.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Sulzer D, Antonini A, Leta V, Nordvig A,
Smeyne RJ, Goldman JE, Al-Dalahmah O, Zecca L, Sette A, Bubacco L,
et al: COVID-19 and possible links with Parkinson's disease and
parkinsonism: From bench to bedside. NPJ Parkinsons Dis.
6(18)2020.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Guedj E, Campion JY, Dudouet P, Kaphan E,
Bregeon F, Tissot-Dupont H, Guis S, Barthelemy F, Habert P,
Ceccaldi M, et al: 18F-FDG brain PET hypometabolism in
patients with long COVID. Eur J Nucl Med Mol Imaging. 48:2823–2833.
2021.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Attademo L and Bernardini F: Are dopamine
and serotonin involved in COVID-19 pathophysiology? Eur J
Psychiatry. 35:62–63. 2021.PubMed/NCBI View Article : Google Scholar
|
